Alexander & Baldwin, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Alexander & Baldwin, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $206.67M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $236.64M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $208.84M | Feb 27, 2026 |
| FY2022 | Dec 31, 2022 | $70.80M | Mar 1, 2023 |
| FY2022 | Sep 30, 2022 | $49.40M | Mar 1, 2023 |
| FY2022 | Jun 30, 2022 | $51.10M | Mar 1, 2023 |
| FY2022 | Mar 31, 2022 | $59.20M | Mar 1, 2023 |
| FY2022 | Dec 31, 2021 | $87.60M | Mar 1, 2023 |
| FY2022 | Sep 30, 2021 | $49.70M | Mar 1, 2023 |
| FY2022 | Jun 30, 2021 | $59.50M | Mar 1, 2023 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $122.70M | Mar 1, 2018 |
| FY2017 | Sep 30, 2017 | $111.50M | Mar 1, 2018 |
| FY2017 | Jun 30, 2017 | $98.10M | Mar 1, 2018 |
| FY2017 | Mar 31, 2017 | $93.20M | Mar 1, 2018 |
| FY2017 | Dec 31, 2016 | $111.20M | Mar 1, 2018 |
| FY2017 | Sep 30, 2016 | $102.90M | Mar 1, 2018 |
| FY2017 | Jun 30, 2016 | $82.00M | Mar 1, 2018 |
| FY2017 | Mar 31, 2016 | $91.40M | Mar 1, 2018 |
| FY2016 | Dec 31, 2015 | $103.30M | Mar 1, 2017 |
| FY2016 | Sep 30, 2015 | $109.50M | Mar 1, 2017 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $64.67M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $60.54M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $29.81M | Feb 27, 2026 |
| FY2022 | Dec 31, 2022 | ($71.60M) | Mar 1, 2023 |
| FY2022 | Sep 30, 2022 | $6.40M | Mar 1, 2023 |
| FY2022 | Jun 30, 2022 | $4.10M | Mar 1, 2023 |
| FY2022 | Mar 31, 2022 | $10.50M | Mar 1, 2023 |
| FY2022 | Dec 31, 2021 | $6.30M | Mar 1, 2023 |
| FY2022 | Sep 30, 2021 | $6.40M | Mar 1, 2023 |
| FY2022 | Jun 30, 2021 | $12.80M | Mar 1, 2023 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $80.02M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $79.77M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $64.63M | Feb 27, 2026 |
| FY2022 | Dec 31, 2022 | $26.90M | Mar 1, 2023 |
| FY2022 | Sep 30, 2022 | $19.00M | Mar 1, 2023 |
| FY2022 | Jun 30, 2022 | $11.80M | Mar 1, 2023 |
| FY2022 | Mar 31, 2022 | $22.40M | Mar 1, 2023 |
| FY2022 | Dec 31, 2021 | $49.50M | Mar 1, 2023 |
| FY2022 | Sep 30, 2021 | $20.80M | Mar 1, 2023 |
| FY2022 | Jun 30, 2021 | $28.70M | Mar 1, 2023 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $28.13M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $29.82M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $34.03M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $35.87M | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $36.60M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $31.10M | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $58.90M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $61.20M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $66.40M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $52.00M | Feb 28, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $79.51M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $97.99M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $67.09M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $33.96M | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $124.20M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $63.10M | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $157.60M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $309.90M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | ($1.30M) | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $111.20M | Feb 28, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.66B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $1.67B | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $1.65B | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $1.79B | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $1.88B | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $2.04B | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $2.08B | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $2.23B | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $2.23B | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $2.16B | Feb 28, 2019 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $672.34M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $666.89M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $643.23M | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $743.60M | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $806.30M | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $933.40M | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $949.30M | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $1.01B | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $1.57B | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | $932.30M | Mar 1, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $987.20M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $1.00B | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $1.00B | Feb 27, 2026 |
| FY2025 | Dec 31, 2022 | $1.04B | Feb 27, 2026 |
| FY2024 | Dec 31, 2021 | $1.07B | Feb 28, 2025 |
| FY2023 | Dec 31, 2020 | $1.10B | Feb 29, 2024 |
| FY2020 | Dec 31, 2019 | $1.13B | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $1.20B | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $646.40M | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | $1.21B | Mar 1, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.73M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $8.73M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $8.73M | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $8.70M | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $8.70M | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $10.50M | Feb 25, 2022 |
| FY2021 | Dec 31, 2019 | $15.40M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $65.10M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $102.30M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $102.30M | Feb 28, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($825.44M) | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | ($814.17M) | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | ($809.33M) | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | ($774.50M) | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | ($663.20M) | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | ($649.40M) | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | ($626.20M) | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | ($538.90M) | Feb 27, 2020 |
| FY2018 | Jan 1, 2018 | ($474.40M) | Feb 28, 2019 |
| FY2018 | Dec 31, 2017 | ($473.00M) | Feb 28, 2019 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $11.30M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $33.44M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $13.52M | Feb 27, 2026 |
| FY2025 | Dec 31, 2022 | $33.26M | Feb 27, 2026 |
| FY2024 | Dec 31, 2021 | $65.42M | Feb 28, 2025 |
| FY2023 | Dec 31, 2020 | $54.90M | Feb 29, 2024 |
| FY2022 | Dec 31, 2019 | $15.20M | Mar 1, 2023 |
| FY2021 | Dec 31, 2018 | $11.40M | Feb 25, 2022 |
| FY2020 | Dec 31, 2017 | $68.90M | Feb 26, 2021 |
| FY2019 | Dec 31, 2016 | $2.20M | Feb 27, 2020 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $491.59M | Feb 27, 2026 |
| FY2024 | Dec 31, 2024 | $474.84M | Feb 28, 2025 |
| FY2023 | Dec 31, 2023 | $464.00M | Feb 29, 2024 |
| FY2023 | Dec 31, 2022 | $472.20M | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $530.80M | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $687.10M | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $704.60M | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $778.10M | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $631.20M | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | $515.10M | Mar 1, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 27, 2026 |
| FY2022 | Dec 31, 2022 | 0 | Mar 1, 2023 |
| FY2022 | Sep 30, 2022 | 0 | Mar 1, 2023 |
| FY2022 | Jun 30, 2022 | 0 | Mar 1, 2023 |
| FY2022 | Mar 31, 2022 | 0 | Mar 1, 2023 |
| FY2022 | Dec 31, 2021 | 0 | Mar 1, 2023 |
| FY2022 | Sep 30, 2021 | 0 | Mar 1, 2023 |
| FY2022 | Jun 30, 2021 | 0 | Mar 1, 2023 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 27, 2026 |
| FY2022 | Dec 31, 2022 | 0 | Mar 1, 2023 |
| FY2022 | Sep 30, 2022 | 0 | Mar 1, 2023 |
| FY2022 | Jun 30, 2022 | 0 | Mar 1, 2023 |
| FY2022 | Mar 31, 2022 | 0 | Mar 1, 2023 |
| FY2022 | Dec 31, 2021 | 0 | Mar 1, 2023 |
| FY2022 | Sep 30, 2021 | 0 | Mar 1, 2023 |
| FY2022 | Jun 30, 2021 | 0 | Mar 1, 2023 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 72.82M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 72.63M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | 72.45M | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | 72.50M | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | 72.50M | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | 72.40M | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | 72.30M | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | 72.00M | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | 49.30M | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | 49.00M | Mar 1, 2018 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $65.71M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $64.98M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $64.27M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $57.72M | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $46.60M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $13.80M | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $50.00M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $156.60M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $10.30M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $12.30M | Feb 28, 2019 |